Global Poultry Live Attenuated Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Poultry Live Attenuated Vaccine market size was valued at USD 2196.8 million in 2023 and is forecast to a readjusted size of USD 2695.7 million by 2030 with a CAGR of 3.0% during review period.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird's immune system to develop a protective response without causing severe illness.
The Global Info Research report includes an overview of the development of the Poultry Live Attenuated Vaccine industry chain, the market status of Chicken (NDV, Marek ' s Disease), Other Poultry (NDV, Marek ' s Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poultry Live Attenuated Vaccine.
Regionally, the report analyzes the Poultry Live Attenuated Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poultry Live Attenuated Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poultry Live Attenuated Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poultry Live Attenuated Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., NDV, Marek ' s Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poultry Live Attenuated Vaccine market.
Regional Analysis: The report involves examining the Poultry Live Attenuated Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poultry Live Attenuated Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poultry Live Attenuated Vaccine:
Company Analysis: Report covers individual Poultry Live Attenuated Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poultry Live Attenuated Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chicken, Other Poultry).
Technology Analysis: Report covers specific technologies relevant to Poultry Live Attenuated Vaccine. It assesses the current state, advancements, and potential future developments in Poultry Live Attenuated Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poultry Live Attenuated Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poultry Live Attenuated Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Poultry Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poultry Live Attenuated Vaccine, with price, sales, revenue and global market share of Poultry Live Attenuated Vaccine from 2019 to 2024.
Chapter 3, the Poultry Live Attenuated Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poultry Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poultry Live Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poultry Live Attenuated Vaccine.
Chapter 14 and 15, to describe Poultry Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird's immune system to develop a protective response without causing severe illness.
The Global Info Research report includes an overview of the development of the Poultry Live Attenuated Vaccine industry chain, the market status of Chicken (NDV, Marek ' s Disease), Other Poultry (NDV, Marek ' s Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poultry Live Attenuated Vaccine.
Regionally, the report analyzes the Poultry Live Attenuated Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poultry Live Attenuated Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poultry Live Attenuated Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poultry Live Attenuated Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., NDV, Marek ' s Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poultry Live Attenuated Vaccine market.
Regional Analysis: The report involves examining the Poultry Live Attenuated Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poultry Live Attenuated Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poultry Live Attenuated Vaccine:
Company Analysis: Report covers individual Poultry Live Attenuated Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poultry Live Attenuated Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chicken, Other Poultry).
Technology Analysis: Report covers specific technologies relevant to Poultry Live Attenuated Vaccine. It assesses the current state, advancements, and potential future developments in Poultry Live Attenuated Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poultry Live Attenuated Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poultry Live Attenuated Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- NDV
- Marek ' s Disease
- IBD
- Infectious Bronchitis
- Influenza
- Other
- Chicken
- Other Poultry
- MERCK
- Boehringer Ingelheim
- CEVA
- ZOETIS
- Vaxxinova
- ELANCO
- QYH BIOTECH
- PULIKE
- PHIBRO ANIMAL HEALTH CORPORATION
- HARBIN PHARMACEUTICAL GROUP
- MEVAC
- VENKY’S
- Dechra
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Poultry Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poultry Live Attenuated Vaccine, with price, sales, revenue and global market share of Poultry Live Attenuated Vaccine from 2019 to 2024.
Chapter 3, the Poultry Live Attenuated Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poultry Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poultry Live Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poultry Live Attenuated Vaccine.
Chapter 14 and 15, to describe Poultry Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Poultry Live Attenuated Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Chicken
1.4.3 Other Poultry
1.5 Global Poultry Live Attenuated Vaccine Market Size & Forecast
1.5.1 Global Poultry Live Attenuated Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poultry Live Attenuated Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poultry Live Attenuated Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 MERCK
2.1.1 MERCK Details
2.1.2 MERCK Major Business
2.1.3 MERCK Poultry Live Attenuated Vaccine Product and Services
2.1.4 MERCK Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 MERCK Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
2.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 CEVA
2.3.1 CEVA Details
2.3.2 CEVA Major Business
2.3.3 CEVA Poultry Live Attenuated Vaccine Product and Services
2.3.4 CEVA Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CEVA Recent Developments/Updates
2.4 ZOETIS
2.4.1 ZOETIS Details
2.4.2 ZOETIS Major Business
2.4.3 ZOETIS Poultry Live Attenuated Vaccine Product and Services
2.4.4 ZOETIS Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ZOETIS Recent Developments/Updates
2.5 Vaxxinova
2.5.1 Vaxxinova Details
2.5.2 Vaxxinova Major Business
2.5.3 Vaxxinova Poultry Live Attenuated Vaccine Product and Services
2.5.4 Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Vaxxinova Recent Developments/Updates
2.6 ELANCO
2.6.1 ELANCO Details
2.6.2 ELANCO Major Business
2.6.3 ELANCO Poultry Live Attenuated Vaccine Product and Services
2.6.4 ELANCO Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ELANCO Recent Developments/Updates
2.7 QYH BIOTECH
2.7.1 QYH BIOTECH Details
2.7.2 QYH BIOTECH Major Business
2.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
2.7.4 QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QYH BIOTECH Recent Developments/Updates
2.8 PULIKE
2.8.1 PULIKE Details
2.8.2 PULIKE Major Business
2.8.3 PULIKE Poultry Live Attenuated Vaccine Product and Services
2.8.4 PULIKE Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 PULIKE Recent Developments/Updates
2.9 PHIBRO ANIMAL HEALTH CORPORATION
2.9.1 PHIBRO ANIMAL HEALTH CORPORATION Details
2.9.2 PHIBRO ANIMAL HEALTH CORPORATION Major Business
2.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
2.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
2.10 HARBIN PHARMACEUTICAL GROUP
2.10.1 HARBIN PHARMACEUTICAL GROUP Details
2.10.2 HARBIN PHARMACEUTICAL GROUP Major Business
2.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
2.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
2.11 MEVAC
2.11.1 MEVAC Details
2.11.2 MEVAC Major Business
2.11.3 MEVAC Poultry Live Attenuated Vaccine Product and Services
2.11.4 MEVAC Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MEVAC Recent Developments/Updates
2.12 VENKY’S
2.12.1 VENKY’S Details
2.12.2 VENKY’S Major Business
2.12.3 VENKY’S Poultry Live Attenuated Vaccine Product and Services
2.12.4 VENKY’S Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 VENKY’S Recent Developments/Updates
2.13 Dechra
2.13.1 Dechra Details
2.13.2 Dechra Major Business
2.13.3 Dechra Poultry Live Attenuated Vaccine Product and Services
2.13.4 Dechra Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Dechra Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POULTRY LIVE ATTENUATED VACCINE BY MANUFACTURER
3.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
3.5 Poultry Live Attenuated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poultry Live Attenuated Vaccine Market: Region Footprint
3.5.2 Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
3.5.3 Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poultry Live Attenuated Vaccine Market Size by Region
4.1.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poultry Live Attenuated Vaccine Average Price by Region (2019-2030)
4.2 North America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.3 Europe Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.5 South America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poultry Live Attenuated Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poultry Live Attenuated Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poultry Live Attenuated Vaccine Market Size by Country
7.3.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poultry Live Attenuated Vaccine Market Size by Country
8.3.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poultry Live Attenuated Vaccine Market Size by Region
9.3.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poultry Live Attenuated Vaccine Market Size by Country
10.3.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poultry Live Attenuated Vaccine Market Size by Country
11.3.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poultry Live Attenuated Vaccine Market Drivers
12.2 Poultry Live Attenuated Vaccine Market Restraints
12.3 Poultry Live Attenuated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poultry Live Attenuated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poultry Live Attenuated Vaccine
13.3 Poultry Live Attenuated Vaccine Production Process
13.4 Poultry Live Attenuated Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poultry Live Attenuated Vaccine Typical Distributors
14.3 Poultry Live Attenuated Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Poultry Live Attenuated Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Chicken
1.4.3 Other Poultry
1.5 Global Poultry Live Attenuated Vaccine Market Size & Forecast
1.5.1 Global Poultry Live Attenuated Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poultry Live Attenuated Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poultry Live Attenuated Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 MERCK
2.1.1 MERCK Details
2.1.2 MERCK Major Business
2.1.3 MERCK Poultry Live Attenuated Vaccine Product and Services
2.1.4 MERCK Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 MERCK Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
2.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 CEVA
2.3.1 CEVA Details
2.3.2 CEVA Major Business
2.3.3 CEVA Poultry Live Attenuated Vaccine Product and Services
2.3.4 CEVA Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CEVA Recent Developments/Updates
2.4 ZOETIS
2.4.1 ZOETIS Details
2.4.2 ZOETIS Major Business
2.4.3 ZOETIS Poultry Live Attenuated Vaccine Product and Services
2.4.4 ZOETIS Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ZOETIS Recent Developments/Updates
2.5 Vaxxinova
2.5.1 Vaxxinova Details
2.5.2 Vaxxinova Major Business
2.5.3 Vaxxinova Poultry Live Attenuated Vaccine Product and Services
2.5.4 Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Vaxxinova Recent Developments/Updates
2.6 ELANCO
2.6.1 ELANCO Details
2.6.2 ELANCO Major Business
2.6.3 ELANCO Poultry Live Attenuated Vaccine Product and Services
2.6.4 ELANCO Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ELANCO Recent Developments/Updates
2.7 QYH BIOTECH
2.7.1 QYH BIOTECH Details
2.7.2 QYH BIOTECH Major Business
2.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
2.7.4 QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QYH BIOTECH Recent Developments/Updates
2.8 PULIKE
2.8.1 PULIKE Details
2.8.2 PULIKE Major Business
2.8.3 PULIKE Poultry Live Attenuated Vaccine Product and Services
2.8.4 PULIKE Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 PULIKE Recent Developments/Updates
2.9 PHIBRO ANIMAL HEALTH CORPORATION
2.9.1 PHIBRO ANIMAL HEALTH CORPORATION Details
2.9.2 PHIBRO ANIMAL HEALTH CORPORATION Major Business
2.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
2.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
2.10 HARBIN PHARMACEUTICAL GROUP
2.10.1 HARBIN PHARMACEUTICAL GROUP Details
2.10.2 HARBIN PHARMACEUTICAL GROUP Major Business
2.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
2.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
2.11 MEVAC
2.11.1 MEVAC Details
2.11.2 MEVAC Major Business
2.11.3 MEVAC Poultry Live Attenuated Vaccine Product and Services
2.11.4 MEVAC Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MEVAC Recent Developments/Updates
2.12 VENKY’S
2.12.1 VENKY’S Details
2.12.2 VENKY’S Major Business
2.12.3 VENKY’S Poultry Live Attenuated Vaccine Product and Services
2.12.4 VENKY’S Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 VENKY’S Recent Developments/Updates
2.13 Dechra
2.13.1 Dechra Details
2.13.2 Dechra Major Business
2.13.3 Dechra Poultry Live Attenuated Vaccine Product and Services
2.13.4 Dechra Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Dechra Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POULTRY LIVE ATTENUATED VACCINE BY MANUFACTURER
3.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2023
3.5 Poultry Live Attenuated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poultry Live Attenuated Vaccine Market: Region Footprint
3.5.2 Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
3.5.3 Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poultry Live Attenuated Vaccine Market Size by Region
4.1.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poultry Live Attenuated Vaccine Average Price by Region (2019-2030)
4.2 North America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.3 Europe Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.5 South America Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poultry Live Attenuated Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poultry Live Attenuated Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poultry Live Attenuated Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poultry Live Attenuated Vaccine Market Size by Country
7.3.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poultry Live Attenuated Vaccine Market Size by Country
8.3.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poultry Live Attenuated Vaccine Market Size by Region
9.3.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poultry Live Attenuated Vaccine Market Size by Country
10.3.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poultry Live Attenuated Vaccine Market Size by Country
11.3.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poultry Live Attenuated Vaccine Market Drivers
12.2 Poultry Live Attenuated Vaccine Market Restraints
12.3 Poultry Live Attenuated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poultry Live Attenuated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poultry Live Attenuated Vaccine
13.3 Poultry Live Attenuated Vaccine Production Process
13.4 Poultry Live Attenuated Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poultry Live Attenuated Vaccine Typical Distributors
14.3 Poultry Live Attenuated Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Poultry Live Attenuated Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poultry Live Attenuated Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. MERCK Basic Information, Manufacturing Base and Competitors
Table 4. MERCK Major Business
Table 5. MERCK Poultry Live Attenuated Vaccine Product and Services
Table 6. MERCK Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. MERCK Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
Table 11. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. CEVA Basic Information, Manufacturing Base and Competitors
Table 14. CEVA Major Business
Table 15. CEVA Poultry Live Attenuated Vaccine Product and Services
Table 16. CEVA Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CEVA Recent Developments/Updates
Table 18. ZOETIS Basic Information, Manufacturing Base and Competitors
Table 19. ZOETIS Major Business
Table 20. ZOETIS Poultry Live Attenuated Vaccine Product and Services
Table 21. ZOETIS Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ZOETIS Recent Developments/Updates
Table 23. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 24. Vaxxinova Major Business
Table 25. Vaxxinova Poultry Live Attenuated Vaccine Product and Services
Table 26. Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Vaxxinova Recent Developments/Updates
Table 28. ELANCO Basic Information, Manufacturing Base and Competitors
Table 29. ELANCO Major Business
Table 30. ELANCO Poultry Live Attenuated Vaccine Product and Services
Table 31. ELANCO Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ELANCO Recent Developments/Updates
Table 33. QYH BIOTECH Basic Information, Manufacturing Base and Competitors
Table 34. QYH BIOTECH Major Business
Table 35. QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
Table 36. QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. QYH BIOTECH Recent Developments/Updates
Table 38. PULIKE Basic Information, Manufacturing Base and Competitors
Table 39. PULIKE Major Business
Table 40. PULIKE Poultry Live Attenuated Vaccine Product and Services
Table 41. PULIKE Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. PULIKE Recent Developments/Updates
Table 43. PHIBRO ANIMAL HEALTH CORPORATION Basic Information, Manufacturing Base and Competitors
Table 44. PHIBRO ANIMAL HEALTH CORPORATION Major Business
Table 45. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
Table 46. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
Table 48. HARBIN PHARMACEUTICAL GROUP Basic Information, Manufacturing Base and Competitors
Table 49. HARBIN PHARMACEUTICAL GROUP Major Business
Table 50. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
Table 51. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
Table 53. MEVAC Basic Information, Manufacturing Base and Competitors
Table 54. MEVAC Major Business
Table 55. MEVAC Poultry Live Attenuated Vaccine Product and Services
Table 56. MEVAC Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. MEVAC Recent Developments/Updates
Table 58. VENKY’S Basic Information, Manufacturing Base and Competitors
Table 59. VENKY’S Major Business
Table 60. VENKY’S Poultry Live Attenuated Vaccine Product and Services
Table 61. VENKY’S Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. VENKY’S Recent Developments/Updates
Table 63. Dechra Basic Information, Manufacturing Base and Competitors
Table 64. Dechra Major Business
Table 65. Dechra Poultry Live Attenuated Vaccine Product and Services
Table 66. Dechra Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Dechra Recent Developments/Updates
Table 68. Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 71. Market Position of Manufacturers in Poultry Live Attenuated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Poultry Live Attenuated Vaccine Production Site of Key Manufacturer
Table 73. Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
Table 74. Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
Table 75. Poultry Live Attenuated Vaccine New Market Entrants and Barriers to Market Entry
Table 76. Poultry Live Attenuated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 78. Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 79. Global Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Poultry Live Attenuated Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 82. Global Poultry Live Attenuated Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 83. Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Global Poultry Live Attenuated Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Poultry Live Attenuated Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 88. Global Poultry Live Attenuated Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 89. Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Global Poultry Live Attenuated Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Poultry Live Attenuated Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 94. Global Poultry Live Attenuated Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 95. North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 96. North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 97. North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 98. North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 99. North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 100. North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 101. North America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 108. Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 109. Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 112. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 113. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 114. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 115. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 116. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 117. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 120. South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 121. South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 122. South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 123. South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 124. South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 125. South America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Poultry Live Attenuated Vaccine Raw Material
Table 136. Key Manufacturers of Poultry Live Attenuated Vaccine Raw Materials
Table 137. Poultry Live Attenuated Vaccine Typical Distributors
Table 138. Poultry Live Attenuated Vaccine Typical Customers
LIST OF FIGURE
s
Figure 1. Poultry Live Attenuated Vaccine Picture
Figure 2. Global Poultry Live Attenuated Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Type in 2023
Figure 4. NDV Examples
Figure 5. Marek ' s Disease Examples
Figure 6. IBD Examples
Figure 7. Infectious Bronchitis Examples
Figure 8. Influenza Examples
Figure 9. Other Examples
Figure 10. Global Poultry Live Attenuated Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Application in 2023
Figure 12. Chicken Examples
Figure 13. Other Poultry Examples
Figure 14. Global Poultry Live Attenuated Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Poultry Live Attenuated Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Poultry Live Attenuated Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Poultry Live Attenuated Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Poultry Live Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Poultry Live Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 56. China Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Poultry Live Attenuated Vaccine Market Drivers
Figure 77. Poultry Live Attenuated Vaccine Market Restraints
Figure 78. Poultry Live Attenuated Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine in 2023
Figure 81. Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
Figure 82. Poultry Live Attenuated Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Table 1. Global Poultry Live Attenuated Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poultry Live Attenuated Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. MERCK Basic Information, Manufacturing Base and Competitors
Table 4. MERCK Major Business
Table 5. MERCK Poultry Live Attenuated Vaccine Product and Services
Table 6. MERCK Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. MERCK Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
Table 11. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. CEVA Basic Information, Manufacturing Base and Competitors
Table 14. CEVA Major Business
Table 15. CEVA Poultry Live Attenuated Vaccine Product and Services
Table 16. CEVA Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CEVA Recent Developments/Updates
Table 18. ZOETIS Basic Information, Manufacturing Base and Competitors
Table 19. ZOETIS Major Business
Table 20. ZOETIS Poultry Live Attenuated Vaccine Product and Services
Table 21. ZOETIS Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ZOETIS Recent Developments/Updates
Table 23. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 24. Vaxxinova Major Business
Table 25. Vaxxinova Poultry Live Attenuated Vaccine Product and Services
Table 26. Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Vaxxinova Recent Developments/Updates
Table 28. ELANCO Basic Information, Manufacturing Base and Competitors
Table 29. ELANCO Major Business
Table 30. ELANCO Poultry Live Attenuated Vaccine Product and Services
Table 31. ELANCO Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ELANCO Recent Developments/Updates
Table 33. QYH BIOTECH Basic Information, Manufacturing Base and Competitors
Table 34. QYH BIOTECH Major Business
Table 35. QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
Table 36. QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. QYH BIOTECH Recent Developments/Updates
Table 38. PULIKE Basic Information, Manufacturing Base and Competitors
Table 39. PULIKE Major Business
Table 40. PULIKE Poultry Live Attenuated Vaccine Product and Services
Table 41. PULIKE Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. PULIKE Recent Developments/Updates
Table 43. PHIBRO ANIMAL HEALTH CORPORATION Basic Information, Manufacturing Base and Competitors
Table 44. PHIBRO ANIMAL HEALTH CORPORATION Major Business
Table 45. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
Table 46. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
Table 48. HARBIN PHARMACEUTICAL GROUP Basic Information, Manufacturing Base and Competitors
Table 49. HARBIN PHARMACEUTICAL GROUP Major Business
Table 50. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
Table 51. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
Table 53. MEVAC Basic Information, Manufacturing Base and Competitors
Table 54. MEVAC Major Business
Table 55. MEVAC Poultry Live Attenuated Vaccine Product and Services
Table 56. MEVAC Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. MEVAC Recent Developments/Updates
Table 58. VENKY’S Basic Information, Manufacturing Base and Competitors
Table 59. VENKY’S Major Business
Table 60. VENKY’S Poultry Live Attenuated Vaccine Product and Services
Table 61. VENKY’S Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. VENKY’S Recent Developments/Updates
Table 63. Dechra Basic Information, Manufacturing Base and Competitors
Table 64. Dechra Major Business
Table 65. Dechra Poultry Live Attenuated Vaccine Product and Services
Table 66. Dechra Poultry Live Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Dechra Recent Developments/Updates
Table 68. Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 71. Market Position of Manufacturers in Poultry Live Attenuated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Poultry Live Attenuated Vaccine Production Site of Key Manufacturer
Table 73. Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
Table 74. Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
Table 75. Poultry Live Attenuated Vaccine New Market Entrants and Barriers to Market Entry
Table 76. Poultry Live Attenuated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 78. Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 79. Global Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Poultry Live Attenuated Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 82. Global Poultry Live Attenuated Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 83. Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Global Poultry Live Attenuated Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Poultry Live Attenuated Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 88. Global Poultry Live Attenuated Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 89. Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Global Poultry Live Attenuated Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Poultry Live Attenuated Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 94. Global Poultry Live Attenuated Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 95. North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 96. North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 97. North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 98. North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 99. North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 100. North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 101. North America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 108. Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 109. Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 112. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 113. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 114. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 115. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 116. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 117. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 120. South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 121. South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 122. South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 123. South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 124. South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 125. South America Poultry Live Attenuated Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Poultry Live Attenuated Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Poultry Live Attenuated Vaccine Raw Material
Table 136. Key Manufacturers of Poultry Live Attenuated Vaccine Raw Materials
Table 137. Poultry Live Attenuated Vaccine Typical Distributors
Table 138. Poultry Live Attenuated Vaccine Typical Customers
LIST OF FIGURE
s
Figure 1. Poultry Live Attenuated Vaccine Picture
Figure 2. Global Poultry Live Attenuated Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Type in 2023
Figure 4. NDV Examples
Figure 5. Marek ' s Disease Examples
Figure 6. IBD Examples
Figure 7. Infectious Bronchitis Examples
Figure 8. Influenza Examples
Figure 9. Other Examples
Figure 10. Global Poultry Live Attenuated Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Application in 2023
Figure 12. Chicken Examples
Figure 13. Other Poultry Examples
Figure 14. Global Poultry Live Attenuated Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Poultry Live Attenuated Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Poultry Live Attenuated Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Poultry Live Attenuated Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Poultry Live Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Poultry Live Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Poultry Live Attenuated Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Poultry Live Attenuated Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Poultry Live Attenuated Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 56. China Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Poultry Live Attenuated Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Poultry Live Attenuated Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Poultry Live Attenuated Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Poultry Live Attenuated Vaccine Market Drivers
Figure 77. Poultry Live Attenuated Vaccine Market Restraints
Figure 78. Poultry Live Attenuated Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine in 2023
Figure 81. Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
Figure 82. Poultry Live Attenuated Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
